-Frontline But in Modi's Gujarat the difference between development and darkness is all too visible to those who care to see. NARENDRA MODI may have won three consecutive elections and ruled Gujarat for more than a decade after he was posted there almost as a night watchman, to borrow a cricketing expression. He may have mobilised a massive fan following that is shouting to catapult him into the Prime Minister's post,...
More »SEARCH RESULT
Crumbs on the plate -Harsh Mander
-The Hindustan Times It now seems increasingly unlikely that Parliament will consider the National Food Security Bill during this budget session. In a land which for centuries suffered devastating famines, where chronic hunger continues to stalk more than 200 million people, and which is home to every third malnourished child on the planet, this would be one more sad betrayal of the country's indigent millions, a reminder of how little they...
More »In the ‘pharmacy of the world’ -PT Jyothi Datta
-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...
More »Dr Purnima Menon, research fellow at the IFPRI's Poverty, Health and Nutrition Division interviewed by Shobha Warrier
-Rediff.com Recently, a study on India's State Hunger Index comparing hunger across all India states was released by Purnima Menon, Anil Deolalikar and Anjor Bhaskar. Dr Purnima Menon is a research fellow at the International Food Policy Research Institute's Poverty, Health and Nutrition Division, and is based at IFPRI's Asia office in New Delhi. She conducts applied nutrition research in the South Asia region, with a focus on programs and policies to improve...
More »Landmark verdict -V Venkatesan
-Frontline The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...
More »